Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kezar Life Sciences, Inc. (KZR) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kezar Life Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1645666.
Total stock buying since 2018: $30,875,307.
Total stock sales since 2018: $3,548,118.
Total stock option exercises since 2018: $364,257.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 825 | $3,530 | 0 | $0 |
| 2024 | 0 | $0 | 6,688 | $3,879 | 0 | $0 |
| 2023 | 0 | $0 | 470,662 | $3,280,959 | 48,950 | $44,055 |
| 2022 | 80,000 | $1,284,200 | 30,000 | $259,750 | 65,060 | $83,604 |
| 2021 | 0 | $0 | 0 | $0 | 34,388 | $177,198 |
| 2020 | 5,573,466 | $18,999,189 | 0 | $0 | 16,000 | $14,400 |
| 2019 | 18,801 | $91,918 | 0 | $0 | 50,000 | $45,000 |
| 2018 | 700,000 | $10,500,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 825 | $3,530 | 0 | $0 |
| 2024-07 | 0 | $0 | 6,688 | $3,879 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 48,950 | $44,055 |
| 2023-02 | 0 | $0 | 155,000 | $1,091,470 | 0 | $0 |
| 2023-01 | 0 | $0 | 315,662 | $2,189,489 | 0 | $0 |
| 2022-12 | 0 | $0 | 25,000 | $177,500 | 0 | $0 |
| 2022-11 | 0 | $0 | 0 | $0 | 27,000 | $24,300 |
| 2022-06 | 0 | $0 | 0 | $0 | 33,060 | $29,754 |
| 2022-03 | 80,000 | $1,284,200 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 5,000 | $82,250 | 5,000 | $29,550 |
| 2021-12 | 0 | $0 | 0 | $0 | 7,700 | $6,930 |
| 2021-09 | 0 | $0 | 0 | $0 | 26,688 | $170,268 |
| 2020-12 | 0 | $0 | 0 | $0 | 16,000 | $14,400 |
| 2020-06 | 1,554,545 | $8,549,997 | 0 | $0 | 0 | $0 |
| 2020-02 | 4,018,921 | $10,449,192 | 0 | $0 | 0 | $0 |
| 2019-12 | 0 | $0 | 0 | $0 | 50,000 | $45,000 |
| 2019-11 | 800 | $2,207 | 0 | $0 | 0 | $0 |
| 2019-10 | 1,000 | $3,235 | 0 | $0 | 0 | $0 |
| 2019-08 | 15,320 | $73,492 | 0 | $0 | 0 | $0 |
| 2019-07 | 931 | $5,342 | 0 | $0 | 0 | $0 |
| 2019-05 | 750 | $7,642 | 0 | $0 | 0 | $0 |
| 2018-06 | 700,000 | $10,500,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-02 | Chiang Pichi Luo (SVP, Corporate Controller) | Sale | 264 | 4.28 | 1,129 |
| 2025-07-02 | Schiller Mark C. (Chief Operating Officer) | Sale | 561 | 4.28 | 2,401 |
| 2024-07-02 | Schiller Mark C. (Chief Legal Officer) | Sale | 6,688 | .58 | 3,879 |
| 2023-07-20 | Kirk Christopher J. (Director) | Option Ex | 48,950 | .90 | 44,055 |
| 2023-02-06 | Morningside Venture Investments Ltd (10% Owner) | Sale | 40,000 | 6.88 | 275,320 |
| 2023-02-03 | Morningside Venture Investments Ltd (10% Owner) | Sale | 25,000 | 7.15 | 178,650 |
| 2023-02-02 | Morningside Venture Investments Ltd (10% Owner) | Sale | 50,000 | 7.19 | 359,500 |
| 2023-02-01 | Morningside Venture Investments Ltd (10% Owner) | Sale | 40,000 | 6.95 | 278,000 |
| 2023-01-31 | Morningside Venture Investments Ltd (10% Owner) | Sale | 30,000 | 7.08 | 212,400 |
| 2023-01-30 | Morningside Venture Investments Ltd (10% Owner) | Sale | 30,000 | 6.91 | 207,300 |
| 2023-01-25 | Morningside Venture Investments Ltd (10% Owner) | Sale | 50,000 | 6.85 | 342,500 |
| 2023-01-24 | Morningside Venture Investments Ltd (10% Owner) | Sale | 80,000 | 6.98 | 558,400 |
| 2023-01-23 | Morningside Venture Investments Ltd (10% Owner) | Sale | 80,000 | 6.81 | 544,800 |
| 2023-01-06 | Morningside Venture Investments Ltd (10% Owner) | Sale | 3,000 | 6.89 | 20,670 |
| 2023-01-05 | Morningside Venture Investments Ltd (10% Owner) | Sale | 12,162 | 6.97 | 84,769 |
| 2023-01-04 | Morningside Venture Investments Ltd (10% Owner) | Sale | 30,000 | 7.17 | 215,100 |
| 2023-01-03 | Morningside Venture Investments Ltd (10% Owner) | Sale | 500 | 7.10 | 3,550 |
| 2022-12-29 | Morningside Venture Investments Ltd (10% Owner) | Sale | 25,000 | 7.10 | 177,500 |
| 2022-11-10 | Fowler John Franklin (CEO) | Option Ex | 27,000 | .90 | 24,300 |
| 2022-06-23 | Kirk Christopher J. (President and CSO) | Option Ex | 33,060 | .90 | 29,754 |
| 2022-03-21 | Berger Franklin M (Director) | Buy | 20,000 | 14.77 | 295,400 |
| 2022-03-18 | Berger Franklin M (Director) | Buy | 60,000 | 16.48 | 988,800 |
| 2022-01-03 | Kauffman Michael (Director) | Sale | 5,000 | 16.45 | 82,250 |
| 2022-01-03 | Kauffman Michael (Director) | Option Ex | 5,000 | 5.91 | 29,550 |
| 2021-12-14 | Fowler John Franklin (CEO) | Option Ex | 7,700 | .90 | 6,930 |
| 2021-09-22 | Berger Franklin M (Director) | Option Ex | 8,896 | 5.60 | 49,817 |
| 2021-09-21 | Berger Franklin M (Director) | Option Ex | 17,792 | 6.77 | 120,451 |
| 2020-12-31 | Fowler John Franklin (CEO) | Option Ex | 16,000 | .90 | 14,400 |
| 2020-06-11 | Equal Talent Investments Ltd (10% Owner) | Buy | 1,454,545 | 5.50 | 7,999,997 |
| 2020-06-11 | Berger Franklin M (Director) | Buy | 100,000 | 5.50 | 550,000 |
| 2020-02-04 | Economides Vassiliki (SVP, Strategy & External Aff.) | Buy | 5,769 | 2.60 | 14,999 |
| 2020-02-04 | Fowler John Franklin (CEO) | Buy | 38,461 | 2.60 | 99,998 |
| 2020-02-04 | Kirk Christopher J. (President and CSO) | Buy | 38,461 | 2.60 | 99,998 |
| 2020-02-04 | Morningside Venture Investments Ltd (10% Owner) | Buy | 3,800,000 | 2.60 | 9,880,000 |
| 2020-02-04 | Belsky Marc (CFO) | Buy | 15,384 | 2.60 | 39,998 |
| 2020-02-04 | Berger Franklin M (Director) | Buy | 120,846 | 2.60 | 314,199 |
| 2019-12-19 | Fowler John Franklin (CEO) | Option Ex | 50,000 | .90 | 45,000 |
| 2019-11-13 | Belsky Marc (CFO) | Buy | 800 | 2.76 | 2,207 |
| 2019-10-10 | Fowler John Franklin (CEO) | Buy | 1,000 | 3.23 | 3,235 |
| 2019-08-20 | Economides Vassiliki (SVP, Strategy & External Aff.) | Buy | 350 | 4.41 | 1,543 |
| 2019-08-20 | Belsky Marc (CFO) | Buy | 200 | 4.42 | 884 |
| 2019-08-13 | Fowler John Franklin (CEO) | Buy | 2,000 | 4.66 | 9,310 |
| 2019-08-13 | Kirk Christopher J. (President and CSO) | Buy | 5,000 | 4.61 | 23,040 |
| 2019-08-09 | Economides Vassiliki (SVP, Strategy & External Aff.) | Buy | 1,020 | 4.96 | 5,057 |
| 2019-08-09 | Fowler John Franklin (CEO) | Buy | 1,250 | 5.13 | 6,418 |
| 2019-08-09 | Kirk Christopher J. (President and CSO) | Buy | 5,000 | 4.97 | 24,830 |
| 2019-08-09 | Belsky Marc (CFO) | Buy | 500 | 4.82 | 2,410 |
| 2019-07-26 | Belsky Marc (CFO) | Buy | 56 | 5.80 | 324 |
| 2019-07-25 | Belsky Marc (CFO) | Buy | 444 | 5.65 | 2,510 |
| 2019-07-22 | Economides Vassiliki (SVP, Strategy & External Aff.) | Buy | 431 | 5.82 | 2,508 |
| 2019-05-30 | Economides Vassiliki (SVP, Strategy & External Aff.) | Buy | 750 | 10.19 | 7,642 |
| 2018-06-25 | Cormorant Global Healthcare Master Fund, Lp | Buy | 250,000 | 15.00 | 3,750,000 |
| 2018-06-25 | Morningside Venture Investments Ltd (10% Owner) | Buy | 250,000 | 15.00 | 3,750,000 |
| 2018-06-25 | Bay City Capital Llc | Buy | 150,000 | 15.00 | 2,250,000 |
| 2018-06-25 | Berger Franklin M (Director) | Buy | 50,000 | 15.00 | 750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of KZR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kezar Life Sciences, Inc. (symbol KZR, CIK number 1645666) see the Securities and Exchange Commission (SEC) website.